Three cases with no available material for cytological evaluation were mutated for KRAS. Upon follow-up two were IPMN, one BD-IPMN and one MD-IPMN with moderate dysplasia. This evidence concerns the gene KRAS and pancreatic intraductal papillary-mucinous neoplasm.